BTI Company Profile

The Biotechnology & Pharmaceuticals company has failed to become profitable despite the epic Surge in Sales the Fresh Tracks Therapeutics Inc over the fourth quarter of 2022

FRTX announced very robust Sales improvement of 1871.154 % year on year to $2.05 millions in the fourth quarter of 2022, but Diminishing Returns have swelled at $-1.70.

Concentrating on the November to January 31 2023 time-frame Rex American Resources Corporation profitability turned positive at $0.46 per share, relative to the recent numbers of $-3.23 per share a year ago quarter, In the previous quarter the Chemical Manufacturing company realized $0.00 per share.

Sales regressed, at LNC during the financial time-frame ending December 31 2022

Softness in Revenues caused bottom-line to tumble by -92.6 % to $0.09 per share, from $1.22 per share, where Sales fell by -8.297 % to $4.22 billions in the fourth quarter of 2022 earnings season, in comparison to same reporting period a year before.

EPS deteriorated while Sales more than doubled the Healthier Choices Management Corp amid the fiscal time-frame closing Dec 31 2022

Regardless of notable Sales growth of 178.874 % year on year to $4.36 millions in the Dec 31 2022 report, Healthier Choices Management Corp s' reached balanced books at $0.00.

A soft Sales elevation at JILL in the financial time-frame ending January 28 2023

Sales elevation of 1.722 %, could not prevent income decline of -72.49 % in the financial time-frame ending January 28 2023, compared to corresponding financial reporting period a year prior. Sales were at $147.65 millions and eps at $0.07.